Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;54(2):81-83.
doi: 10.5045/br.2019.54.2.81. Epub 2019 Jun 25.

Chimeric antigen T cell receptor treatment in hematological malignancies

Natasha Ali  1 ; FCPS Haematology
Affiliations

Chimeric antigen T cell receptor treatment in hematological malignancies

Natasha Ali et al. Blood Res. 2019 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors' Disclosures of Potential Conflict of Interest: No potential conflict of interests relevant to article were reported.

References

    1. Bartenstein M, Deeg HJ. Hematopoietic stem cell transplantation for MDS. Hematol Oncol Clin North Am. 2010;24:407–422. - PMC - PubMed
    1. Eshhar Z, Waks T, Gross G, Schindler DG. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A. 1993;90:720–724. - PMC - PubMed
    1. Sadelain M, Rivière I, Brentjens R. Targeting tumours with genetically enhanced T lymphocytes. Nat Rev Cancer. 2003;3:35–45. - PubMed
    1. Wohlfarth P, Worel N, Hopfinger G. Chimeric antigen receptor TXMLLink_XYZcell therapy-a hematological success story. Memo. 2018;11:116–121. - PMC - PubMed
    1. Locke FL, Ghobadi A, Jacobson CA, et al. Durability of response in ZUMA-1, the pivotal phase 2 study of axicabtagene ciloleucel (Axi-Cel) in patients (Pts) with refractory large B-cell lymphoma. J Clin Oncol. 2018;36(Suppl):abst 3003.